Bard Associates Inc Nephros Inc Transaction History

Bard Associates Inc

  • $234 Million
  • Q1 2025

A detailed history of Bard Associates Inc transactions in Nephros Inc stock. As of the latest transaction made, Bard Associates Inc holds 143,221 shares of NEPH stock, worth $468,332. This represents 0.11% of its overall portfolio holdings.

Number of Shares
143,221
Previous 155,271 7.76%
Holding current value
$468,332
Previous $229,000 7.42%
% of portfolio
0.11%
Previous 0.09%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$1.41 - $1.72 $16,990 - $20,726
-12,050 Reduced 7.76%
143,221 $246,000
Q4 2024

Feb 06, 2025
SELL
$1.36 - $1.69 $23,256 - $28,899
-17,100 Reduced 9.92%
155,271 $229,000
Q3 2024

Nov 06, 2024
SELL
$1.71 - $2.29 $5,514 - $7,385
-3,225 Reduced 1.84%
172,371 $294,000
Q2 2024

Aug 12, 2024
SELL
$1.99 - $2.36 $7,522 - $8,920
-3,780 Reduced 2.11%
175,596 $370,000
Q1 2024

May 13, 2024
SELL
$2.11 - $3.78 $16,757 - $30,020
-7,942 Reduced 4.24%
179,376 $392,000
Q4 2023

Feb 13, 2024
BUY
$1.46 - $3.91 $1,867 - $5,000
1,279 Added 0.69%
187,318 $648,000
Q3 2023

Nov 13, 2023
SELL
$1.35 - $1.72 $9,315 - $11,868
-6,900 Reduced 3.58%
186,039 $275,000
Q2 2023

Aug 11, 2023
SELL
$1.14 - $2.02 $1,538 - $2,727
-1,350 Reduced 0.69%
192,939 $299,000
Q1 2023

May 12, 2023
SELL
$0.97 - $1.35 $485 - $675
-500 Reduced 0.26%
194,289 $207,000
Q4 2022

Feb 10, 2023
SELL
$0.93 - $1.25 $53,321 - $71,668
-57,335 Reduced 22.74%
194,789 $225,000
Q3 2022

Nov 09, 2022
SELL
$0.91 - $1.87 $10,583 - $21,748
-11,630 Reduced 4.41%
252,124 $229,000
Q2 2022

Aug 11, 2022
BUY
$1.47 - $4.63 $25,498 - $80,311
17,346 Added 7.04%
263,754 $404,000
Q1 2022

May 11, 2022
BUY
$3.89 - $6.12 $54,071 - $85,068
13,900 Added 5.98%
246,408 $1.08 Million
Q4 2021

Feb 14, 2022
SELL
$5.87 - $8.46 $9,979 - $14,382
-1,700 Reduced 0.73%
232,508 $1.37 Million
Q3 2021

Nov 12, 2021
BUY
$7.6 - $10.01 $20,520 - $27,027
2,700 Added 1.17%
234,208 $2.05 Million
Q2 2021

Aug 12, 2021
BUY
$6.61 - $10.68 $80,179 - $129,548
12,130 Added 5.53%
231,508 $2.35 Million
Q1 2021

May 13, 2021
BUY
$6.65 - $8.93 $83,324 - $111,892
12,530 Added 6.06%
219,378 $1.46 Million
Q4 2020

Feb 11, 2021
BUY
$5.86 - $8.58 $29,593 - $43,329
5,050 Added 2.5%
206,848 $1.78 Million
Q3 2020

Nov 12, 2020
SELL
$5.58 - $8.45 $3,744 - $5,669
-671 Reduced 0.33%
201,798 $1.46 Million
Q2 2020

Aug 13, 2020
SELL
$6.15 - $9.35 $31,365 - $47,685
-5,100 Reduced 2.46%
202,469 $1.7 Million
Q1 2020

May 13, 2020
BUY
$5.99 - $10.29 $1.24 Million - $2.14 Million
207,569 New
207,569 $2.64 Million

Others Institutions Holding NEPH

# of Institutions
18
Shares Held
4.24M
Call Options Held
0
Put Options Held
0
View Full List

About NEPHROS INC

NEPH Quotes by TradingView
  • Ticker NEPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 10,318,800
  • Market Cap $33.7M
  • Description
  • Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...
More about NEPH
Track This Portfolio

Track Bard Associates Inc Portfolio

Follow Bard Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bard Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email